Copyright
©The Author(s) 1999.
World J Gastroenterol. Dec 15, 1999; 5(6): 477-482
Published online Dec 15, 1999. doi: 10.3748/wjg.v5.i6.477
Published online Dec 15, 1999. doi: 10.3748/wjg.v5.i6.477
Figure 2 Effects of indomethacin and L-NAME on the mucosal protective action of irsogladine and rebamipide against NH2Cl-induced gastric lesions in rats.
The animals were administered po with 1 mL of NH2Cl (120 mM), and sacrificed 1 h later. Irsogladine (3 mg/kg) or rebamipide (100 mg/kg) was given po 30 min before NH2Cl treat ment. Indomethacin (5 mg/kg, sc) or L-NAME (10 mg/kg, iv) was given 30 or 10 min before the above agents. Data are presented as the mean ± SE from 5-8 rats. Statistically significant difference at P < 0.05; *from the corresponding control (CMC);#from the corresponding value in normal group.
- Citation: Yamamoto H, Umeda M, Mizoguchi H, Kato S, Takeuchi K. Protective effect of Irsogladine on monochloramine induced gastric mucosal lesions in rats: a comparative study with rebamipide. World J Gastroenterol 1999; 5(6): 477-482
- URL: https://www.wjgnet.com/1007-9327/full/v5/i6/477.htm
- DOI: https://dx.doi.org/10.3748/wjg.v5.i6.477